HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyperaldosteronism (Conn Syndrome)

A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.
Also Known As:
Conn Syndrome; Aldosteronism; Syndrome, Conn; Conn's Syndrome; Primary Hyperaldosteronism; Conns Syndrome; Hyperaldosteronism, Primary; Syndrome, Conn's
Networked: 4756 relevant articles (208 outcomes, 410 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Hypertension (High Blood Pressure)
2. Adenoma (Adenomas)
3. Hyperplasia
4. Hypokalemia
5. Essential Hypertension

Experts

1. Reincke, Martin: 101 articles (11/2022 - 12/2003)
2. Rossi, Gian Paolo: 84 articles (11/2022 - 07/2002)
3. Wu, Vin-Cent: 70 articles (10/2022 - 08/2009)
4. Mulatero, Paolo: 67 articles (01/2022 - 07/2002)
5. Sasano, Hironobu: 62 articles (03/2022 - 03/2002)
6. Stowasser, Michael: 60 articles (01/2022 - 02/2002)
7. Lin, Yen-Hung: 58 articles (10/2022 - 08/2009)
8. Beuschlein, Felix: 55 articles (01/2022 - 03/2004)
9. Satoh, Fumitoshi: 51 articles (11/2022 - 08/2006)
10. Naruse, Mitsuhide: 49 articles (11/2022 - 06/2003)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Hyperaldosteronism:
1. AldosteroneIBA
2. Spironolactone (Aldactone)FDA LinkGeneric
3. ReninIBA
4. Antihypertensive Agents (Antihypertensives)IBA
5. Mineralocorticoid Receptor AntagonistsIBA
6. PotassiumIBA
7. Eplerenone (Inspra)FDA LinkGeneric
8. SodiumIBA
9. Hydrocortisone (Cortisol)FDA LinkGeneric
10. Dexamethasone (Maxidex)FDA LinkGeneric

Therapies and Procedures

1. Adrenalectomy
2. Therapeutics
3. Aftercare (After-Treatment)
4. Drug Therapy (Chemotherapy)
5. Radiofrequency Ablation